News

 

 

AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies for antibiotic-resistant infections using bacteriophage technology, announces that data from its investigational bacteriophage programs,...

Read more about AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences

FDA Approves Increased Compassionate Use Patient Cases and Sites for ReCell®

Valencia, CA, Perth, Australia and London, United Kingdom, 7 April 2017 – link here

Read more about FDA Approves Increased Compassionate Use Patient Cases and Sites for ReCell®

Adherium chosen as Finalist in NZ Hi-Tech Awards

Entries this year came from as far afield as Kaitaia and Invercargill which have resulted in a record number of entries being received, up 30% on last year.

Read more about Adherium chosen as Finalist in NZ Hi-Tech Awards

AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies for antibiotic-resistant infections using bacteriophage technology, today announced financial results for the quarter and...

Read more about AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights

Avita Medical to Present at Needham Healthcare Conference

Valencia, CA, USA, Perth, Australia and London, United Kingdom, 23 March 2017 — Link here

Read more about Avita Medical to Present at Needham Healthcare Conference

Come meet Adherium at RDD Europe 2017

Garth Sutherland, Adherium CEO & Founder, selected as a Speaker and author at the upcoming meeting, RDD Europe 2017 to be held April 25-28, 2017, at Palais des Congres d'Antibes, Nice (Antibes), France.

Read more about Come meet Adherium at RDD Europe 2017

Avita Announces $975k R & D Tax Incentive

Valencia, CA, USA, Perth, Australia and Cambridge, United Kingdom, 16 March 2017 — Link here

Read more about Avita Announces $975k R & D Tax Incentive

Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

Clinical data collected from final patient, completing trial • Company plans PMA submission upon receipt of shelf-life stability data • PMA decision anticipated during the 2nd calendar quarter of 2018...

Read more about Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference

DUBLIN, Ireland, Feb. 22, 2017 (GLOBE NEWSWIRE) --Link here

Read more about Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference

Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

Clinical data collected from final patient, completing trial • Company plans PMA submission upon receipt of shelf-life stability data • PMA decision anticipated during the 2nd calendar quarter of 2018...

Read more about Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial

1 2 3 4 5 ... 22